Ross\Johnson & Associates’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51 Buy
+1
New +$61 ﹤0.01% 340
2025
Q2
Sell
-40
Closed -$3.66K 243
2025
Q1
$3.66K Buy
+40
New +$3.49K 0.06% 109

Other funds holding DOX

Ross\Johnson & Associates's DOX Position: Q2 2026 in Review

Ross\Johnson & Associates opened a new position in Amdocs (DOX) in Q2 2026: 1 share worth $51. The stake represents ﹤0.01% of the portfolio and ranks #340 among its holdings. This is a return to the name: Ross\Johnson & Associates previously reported a position in DOX as recently as Q1 2025.

Ross\Johnson & Associates first reported a position in DOX in Q1 2025 and has held it in 2 quarters since. The position peaked at $3.66K in Q1 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Ross\Johnson & Associates held 1 share of Amdocs worth $51 as of Q2 2026.
  • Amdocs was a new Ross\Johnson & Associates position in Q2 2026.
  • Amdocs made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #340 holding.
  • Ross\Johnson & Associates first reported a position in Amdocs in Q1 2025 and has held it in 2 quarters since.
  • Ross\Johnson & Associates's Amdocs position peaked at $3.66K in Q1 2025.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.